TrialClinical and experimental rheumatology

Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial.

Lisa G Rider et al.PubMed ↗Full text ↗

No numbers read from the abstract.